Search

Your search keyword '"Natasa Rajicic"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Natasa Rajicic" Remove constraint Author: "Natasa Rajicic" Topic business.industry Remove constraint Topic: business.industry
22 results on '"Natasa Rajicic"'

Search Results

1. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

2. SUN-LB079 Acrostudy - Safety And Treatment Outcomes In 2221 Patients With Acromegaly Treated With Pegvisomant: Real World Experience

4. A test for the relationship between a time-varying marker and both recovery and progression with missing data

5. CD4+ T-Cell Restoration After 48 Weeks in the Maraviroc Treatment-Experienced Trials MOTIVATE 1 and 2

6. Analysis of the relationship between longitudinal gene expressions and ordered categorical event data

7. Occult Hepatitis B in HIV-Infected Patients

8. Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study

9. A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing

10. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection

11. Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial

12. Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyads

13. Concurrent use of statins does not influence efficacy of maraviroc in Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients 1 and 2 trials

14. Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy

15. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS

16. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group

18. Identification and Interpretation of Longitudinal Gene Expression Changes in Trauma

20. Incidence of infections in treatment-experienced (TE) patients in the MOTIVATE studies of maraviroc (MVC) plus optimized background therapy (OBT)

21. ERRATUM

22. O425 Efficacy and safety of maraviroc in treatment-experienced (TE) patients infected with R5 HIV-1: 96-week combined analysis of the MOTIVATE 1 and 2 studies

Catalog

Books, media, physical & digital resources